Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies Life Science
Healthcare Roundup – GlycoMimetics out-licenses two programs, OrthoPediatrics sells Vilex adult business Life Science
Biotech Co. Ltd. Announced Completion of Merger, Appointed Yingshuang Chai as CEO, and Established Collaboration with Illumina Life Science
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment Life Science
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing Life Science
Healthcare Roundup – MyoKardia inks $200M stock sales deal, Charles River Labs closes HemaCare acquisition Life Science
Healthcare Roundup – Illumina and Pacific Biosciences nix merger, Tilray inks deal to export weed into Israel Life Science
Healthcare Roundup – EyeGate Pharma files for 500K-share stock offering, Drugmakers to hike U.S. prices Life Science
Healthcare Roundup – XBiotech says bermekimab sale to J&J closes, Acceleron Pharma teams up with Fulcrum Therapeutics Life Science
Healthcare – Sanofi begins tender offer for Synthorx buy-out, Regeneron’s Ebola treatment gets orphan status Life Science
TRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue Sarcoma Life Science
Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies Life Science
